Corbus Pharmaceuticals Holdings, Inc.

CRBP · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$23-$18-$17-$10
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$2$0
Change in WC$6$0-$1-$3
Other Non-Cash-$0-$1-$0$1
Operating Cash Flow-$16-$17-$16-$11
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$18-$18-$38-$11
Inv. Sales/Matur.$37$35$56$20
Other Inv. Act.$0$0$0$0
Investing Cash Flow$20$18$18$9
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$3$0$0-$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$3$0$0-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$7$1$2-$2
Supplemental Information
Beg. Cash$21$20$18$20
End Cash$28$21$20$17
Free Cash Flow-$16-$17-$16-$11
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Financial Statements & Key Stats | AlphaPilot